Effect of Cabergoline on Weight and Glucose Tolerance

Clinical trial NCT01395602 · COMPLETED

Trial details

NCT number: NCT01395602
Sponsor: Columbia University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Body Weight Impaired Glucose Tolerance in Obese

Start date: 2002-04-01
Primary completion: 2003-09-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.